Vandetanib is effective in EGFR-mutant lung cancer cells with PTEN deficiency

Hiromasa Takeda, Nagio Takigawa, Kadoaki Ohashi, Daisuke Minami, Itaru Kataoka, Eiki Ichihara, Nobuaki Ochi, Mitsune Tanimoto, Katsuyuki Kiura

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Fingerprint Dive into the research topics of 'Vandetanib is effective in EGFR-mutant lung cancer cells with PTEN deficiency'. Together they form a unique fingerprint.

Medicine & Life Sciences